Medipyxis
blog8 min read

Surgical Wound Dehiscence: Home Management for Mobile Wound Care

Managing surgical wound dehiscence in mobile wound care — assessment, global surgical period implications, NPWT candidacy, and when to refer back.

D

Damon Ebanks

Medipyxis

Surgical Wound Dehiscence: Home Management for Mobile Wound Care

Surgical Wound Dehiscence: Home Management for Mobile Wound Care

Effective surgical wound dehiscence management begins when a mobile wound care practitioner receives a referral from a surgeon's office — and it happens more often than most clinicians expect. The patient has had their procedure, been discharged, and developed a wound complication that the surgical practice is either unable or unwilling to manage in their outpatient clinic. The wound care specialist inherits a wound with a defined surgical history, a ticking global surgical period clock, and a patient who is anxious about what went wrong.

Managing dehiscence in the mobile setting requires understanding when the wound falls within the surgeon's responsibility, when it becomes independently billable wound care, and when the patient needs to go back to the operating room rather than continuing conservative management.


Initial Assessment: What Happened and What Are We Looking At

The first visit to a dehisced surgical wound is a diagnostic visit, not a treatment visit. Before touching the wound, establish the clinical picture:

Surgical history:

  • What was the procedure? Date of surgery. Surgeon's name and contact information.
  • Was the closure primary (sutures, staples, adhesive) or was a flap or graft involved?
  • Were drains placed? Have they been removed?
  • Has the patient had prior dehiscence at this site or prior surgeries in this area?
  • Is the patient on anticoagulants, steroids, immunosuppressants, or chemotherapy?

Wound assessment:

  • Extent of dehiscence: Partial (superficial separation with intact deeper layers) or complete (full-thickness separation through all layers including fascia).
  • Wound bed: Viable granulation, slough, necrotic tissue, exposed structures (fascia, muscle, tendon, bone, mesh, hardware).
  • Signs of infection: Erythema extending beyond the wound margin, warmth, induration, purulent drainage, foul odor, systemic signs (fever, elevated WBC if labs are available).
  • Wound dimensions: Length, width, depth, undermining, tunneling. Measure and document — this is your baseline for tracking healing trajectory.
  • Drainage: Amount (scant, moderate, copious), type (serous, serosanguinous, sanguinous, purulent).

Critical finding: fascial dehiscence. If the fascia has separated and you can visualize or palpate abdominal contents, bowel, or other visceral structures — this is a surgical emergency. Cover the wound with a sterile saline-moistened dressing, keep the patient supine, and arrange immediate surgical evaluation. Do not attempt wound care management of an open abdomen in the home setting.


The Global Surgical Period: Who Bills for This

The global surgical period is the window during which all routine postoperative care — including wound management — is included in the surgeon's original procedure payment. This directly affects whether you can bill for wound care services.

Key rules:

  • Major procedures (90-day global): Most abdominal, orthopedic, and thoracic surgeries carry a 90-day global period. Routine wound care during this period is the surgeon's responsibility.
  • Minor procedures (10-day global): Smaller procedures carry a 10-day global period.
  • Modifier 24: If the wound care you are providing is for a complication that is unrelated to the original procedure, or if the nature of the wound care exceeds routine postoperative management, modifier 24 (unrelated E/M during the global period) may apply. This requires documentation clearly establishing that the services are distinct from routine postoperative care.
  • Modifier 79: A new procedure performed during the postoperative period of the original procedure, unrelated to the original.

The practical reality: Most dehiscence referrals come because the wound care required has exceeded what the surgeon considers routine postoperative management. The referring surgeon is effectively acknowledging that this wound now needs specialized wound management. Document the referral, the surgeon's statement regarding the nature of the wound complication, and the treatment plan you are initiating. This supports the medical necessity for independent billing.

Coordinate with your billing team before the first visit to confirm the global period status and the appropriate modifiers. A dehiscence claim denied because it fell within an active global period — with no modifier documentation — is a preventable administrative failure.


Surgical Wound Dehiscence Management Protocol

Treatment depends on the depth and cleanliness of the wound:

Superficial Dehiscence (Epidermis/Dermis Only)

Intact fascial layer with separation of the superficial closure. The wound bed is typically clean and granulating if the dehiscence is recent.

  • Gentle irrigation with normal saline
  • Moist wound healing with non-adherent primary dressing
  • Skin closure strips (Steri-Strips) if edges can be approximated without tension
  • Weekly reassessment with wound measurements
  • Monitor for signs of deeper separation or infection

Partial-Thickness Dehiscence (Through Subcutaneous Tissue)

Separation extends into the subcutaneous fat but fascia remains intact.

  • Debridement of nonviable tissue if present (autolytic or conservative sharp)
  • Wound packing if depth requires it — moist gauze or foam fillers to prevent premature surface closure and abscess formation
  • Appropriate moisture-balanced secondary dressing
  • Reassessment at minimum twice weekly initially
  • Culture if signs of infection are present — treat based on culture results, not empirically unless clinical urgency requires it

Full-Thickness Dehiscence (Through Fascia, No Evisceration)

Fascial separation with exposed deeper structures but no visceral herniation or evisceration.

  • Surgical consultation — this wound may need operative reclosure
  • If managing conservatively per surgical direction: negative pressure wound therapy (NPWT) is the primary consideration for wounds of this depth and complexity
  • Protect exposed structures from desiccation
  • Twice-weekly or more frequent visits depending on drainage volume and wound stability

NPWT Candidacy in Dehiscence

Negative pressure wound therapy is frequently the most effective modality for managing dehisced surgical wounds that are too deep or too large for primary dressing management alone. The decision to initiate NPWT should be based on clinical criteria, not wound size alone.

Good candidates for NPWT:

  • Partial or full-thickness dehiscence with a clean, granulating wound bed (or a wound bed that can be debrided to viable tissue)
  • Moderate to heavy exudate that standard dressings cannot manage
  • Wounds with significant depth or undermining where packing is ineffective
  • Patient is expected to tolerate the device and maintain the seal between visits
  • Adequate perfusion to support tissue response to negative pressure

Poor candidates for NPWT:

  • Untreated osteomyelitis or deep infection
  • Exposed blood vessels, organs, or anastomotic sites
  • Active malignancy in the wound bed
  • Patient unable to manage or tolerate the device
  • Inadequate arterial perfusion (ABI <0.5)

Documentation for NPWT initiation:

  • Wound measurements and depth
  • Failed or inadequate response to standard wound care (document duration and modalities tried)
  • Clinical rationale for NPWT selection over standard dressings
  • Treatment goals — granulation tissue promotion, exudate management, wound volume reduction, preparation for secondary closure or grafting

For complete NPWT billing guidance, see the NPWT Billing Guide.


When to Refer Back to the Surgeon

Not every dehiscence is a wound-care-only problem. Refer the patient back to the operating surgeon or to surgical consultation when:

  • Fascial dehiscence with any evisceration — surgical emergency
  • Exposed hardware, mesh, or prosthetic material — these implants rarely granulate over with conservative management and frequently require operative revision
  • Deep space infection or abscess — requires incision and drainage in a controlled surgical setting, not bedside management
  • Wound failing to progress after 4 weeks of appropriate therapy — reassess whether the wound can heal by secondary intention or needs operative intervention
  • Exposed bowel, blood vessels, or other critical structures — operative coverage required
  • Dehiscence at a high-tension closure site (abdominal midline, sternotomy) where reclosure under anesthesia may be more effective than months of secondary intention healing

Document every referral conversation — who was called, what was discussed, what the recommendation was, and whether the patient followed through. If the surgeon declines to re-intervene and directs continued conservative management, document that directive and the clinical rationale provided.


Risk Factor Documentation

Document the contributing factors that led to dehiscence. This supports medical necessity, informs the treatment plan, and protects against audit questions about why the wound exists:

  • Nutritional status: Prealbumin <15 mg/dL is associated with impaired wound healing. Coordinate with dietary or the PCP for optimization.
  • Diabetes: Document HbA1c and current glycemic control.
  • Obesity: Increased wound tension and reduced perfusion to subcutaneous tissue.
  • Immunosuppression: Steroids, chemotherapy, biologics, organ transplant medications.
  • Smoking status: Active tobacco use impairs all phases of wound healing.
  • Mechanical factors: Premature heavy lifting, coughing (post-thoracic or abdominal surgery), wound tension from obesity or edema.

Key Takeaways

  • Verify global surgical period status before billing -- wound care within 90 days of the original surgery may be bundled under the surgeon's global period unless a new diagnosis (wound dehiscence) justifies separate billing
  • Document contributing risk factors (nutritional status, diabetes control, obesity, immunosuppression, mechanical factors) to support medical necessity and inform the treatment plan
  • NPWT is indicated for dehiscence with significant tissue loss, undermining, or depth that precludes primary reclosure -- document the clinical rationale for advanced therapy initiation
  • Refer back to the surgeon when evisceration occurs, hardware or prosthetic material is exposed, or when reclosure under anesthesia may be more effective than months of secondary intention healing

Related: NPWT Billing Guide | Wound Care Billing Guide | CPT Code Reference

Want to learn more about Medipyxis?

Explore how mobile wound care practices use Medipyxis to reduce denials and capture more referrals.